DEVELOPMENT AND METHODOLOGY FOR THE ESTIMATION OF LISINOPRIL AND ATORVASTATIN IN PHARMACEUTICALS

Authors

  • D. B. Koval VOLYN MEDICAL INSTITUTE OF THE VOLYN OBLAST COUNSIL, LUTSK
  • N. S. Shulyak I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY
  • L. S. Logoyda VOLYN MEDICAL INSTITUTE OF THE VOLYN OBLAST COUNSIL, LUTSK

DOI:

https://doi.org/10.11603/mcch.2410-681X.2020.v.i3.11532

Keywords:

lisinopril and atorvastatin, identification, thin layer chromatography, validation

Abstract

Introduction. The cause of hypertension and coronary heart disease in most cases is hypercholesterolemia. Therefore, for the treatment and prevention of most pharmacotherapy regimens, antiatherosclerotic drugs are used. With a high class of recommendations and level of evidence, high efficiency for primary and secondary prevention of coronary heart disease, statins are widely used in clinical practice.

The aim of the study – to improve more rapid, simple, selective, less expensive methods of thin layer chromatography analysis of simultaneous determination of lisinopril and atorvastatin in pharmaceuticals.

Research Methods. The present study assessed mobile phases of lisinopril and atorvastatin for TLC.

Results and Discussion. Thin layer chromatography can be used to: monitor the progress of a reaction, identify compounds, determine the purity of a substance. Method of simultaneous identification of lisinopril and atorvastatin by TLC was developed. We investigated different mobile phases to optimize the development of analytical methods of lisinopril and atorvastatin by TLC. It was established that the most optimal Rf observed using mobile phase ammonia R (25 %) – propanol R (30:70, v/v). We explored the validation characteristics – specificity and suitability of the chromatographic system that met, the eligibility criteria established by the SPhU.

Conclusions. We developed chromatographic method for simultaneous determination of lisinopril and atorvastatin. Propects for future research will be aimed at developing analytical methods of analysis.

References

Lippi, G., Mattiuzzi, C., & Cervellin, G. (2019). Statins popularity: A Global picture to statins. Br. J. Clin. Pharmacol., 85, 1614-1615. https://doi.org/10.1111/bcp.13944

Bele, A.A., & Khale, A. (2011). An overview on thin layer chromatography. Int. J. Pharm. Sci. Res., 2 (2), 256-267.

Singhal, S., Singhal, N., & Agarwal, S. (2009). Pharmaceutical analysis II. Thin layer chromatography. Pragati prakashan. 1st edn.

Kasture, A.V., Mahadik, K.R., Wadodkar, S.G., & More, H.N. (2005). A textbook of pharmaceutical analysis. Instrumental methods. Nirali Prakashan. 9th edn.

Quach, H.T., Steeper, R.L., & Griffin, G.W. (2004). Separation of plant pigments by thin layer chromatography. J. Chem. Educ., 81, 385-387.

Skoog, D.A., Holler, F.J., & Nieman, T.A. (2006). Principles of instrumental analysis. Saunders college publishing. 5th edn.

Chatwal, G.R., & Anand, S.K. (2008). Instrumental methods of chemical analysis. Himalaya publishing house. 5th edn.

Beckett, A.H., & Stenlake, J.B. (2005). Practical pharmaceutical chemistry. Thin layer chromatography. CBS publishers. 4th edn.

Ali, M., & Agrawal, V. (2002). Thin-layer chroma­tography of aromatic amines. Separ. Sci. Technol., 37, 363-377.

Sharma, B.K. (2007). Instrumental methods of chemical analysis. Meerut: Goel publishing house. 5th edn., pp. 241-264.

Logoyda, L. (2017). Development and metho­dology for the estimation of bisoprolol in pharmaceuticals. Med. Clin. Chem., 2, 34-37.

ICH Topic. Q2 (R1) Validation of Analytical Procedures: Text and methodology.

Sagar, V. (2009). Instrumental methods of drug analysis. Pharma Med. Press. 1st edn.

Published

2020-12-02

How to Cite

Koval, D. B., Shulyak, N. S., & Logoyda, L. S. (2020). DEVELOPMENT AND METHODOLOGY FOR THE ESTIMATION OF LISINOPRIL AND ATORVASTATIN IN PHARMACEUTICALS. Medical and Clinical Chemistry, (3), 38–42. https://doi.org/10.11603/mcch.2410-681X.2020.v.i3.11532

Issue

Section

ORIGINAL INVESTIGATIONS